SlideShare a Scribd company logo
EUROPEAN COMMISSION
HEALTH AND CONSUMERS DIRECTORATE-GENERAL
Health Systems and Products
Medicinal Products - Quality, safety and efficacy
Brussels,
SANCO/AM/sl/ddg1.d.6(2012)860362
EudraLex
The Rules Governing Medicinal Products in the European Union
Volume 4
EU Guidelines for
Good Manufacturing Practice for
Medicinal Products for Human and Veterinary Use
Chapter 7
Outsourced Activities
Legal basis for publishing the detailed guidelines: Article 47 of Directive
2001/83/EC on the Community code relating to medicinal products for human use and
Article 51 of Directive 2001/82/EC on the Community code relating to veterinary
medicinal products. This document provides guidance for the interpretation of the
principles and guidelines of good manufacturing practice (GMP) for medicinal
products as laid down in Directive 2003/94/EC for medicinal products for human use
and Directive 91/412/EEC for veterinary use.
Status of the document: revision 1
Reasons for changes: In view of the ICH Q10 guideline on the Pharmaceutical
Quality System, Chapter 7 of the GMP Guide has been revised in order to provide
updated guidance on outsourced GMP regulated activities beyond the current scope of
contract manufacture and analysis operations. The title of the Chapter has been
changed to reflect this.
Deadline for coming into operation: 31 January 2013
Ref. Ares(2012)778531 - 28/06/2012
Commission Européenne, B-1049 Bruxelles / Europese Commissie, B-1049 Brussel – Belgium. Telephone: (32-2) 299 11 11
Principle
Any activity covered by the GMP Guide that is outsourced should be appropriately
defined, agreed and controlled in order to avoid misunderstandings which could result
in a product or operation of unsatisfactory quality. There must be a written Contract
between the Contract Giver and the Contract Acceptor which clearly establishes the
duties of each party. The Quality Management System of the Contract Giver must
clearly state the way that the Qualified Person certifying each batch of product for
release exercises his full responsibility.
Note: This Chapter deals with the responsibilities of manufacturers towards the
Competent Authorities of the Member States with respect to the granting of marketing
and manufacturing authorizations. It is not intended in any way to affect the
respective liability of Contract Acceptors and Contract Givers to consumers; this is
governed by other provisions of Community and national law.
General
7.1 There should be a written Contract covering the outsourced activities, the
products or operations to which they are related, and any technical arrangements
made in connection with it.
7.2 All arrangements for the outsourced activities including any proposed changes
in technical or other arrangements should be in accordance with regulations in force,
and the Marketing Authorisation for the product concerned, where applicable.
7.3 Where the marketing authorization holder and the manufacturer are not the
same, appropriate arrangements should be in place, taking into account the principles
described in this chapter.
The Contract Giver
7.4 The pharmaceutical quality system of the Contract Giver should include the
control and review of any outsourced activities. The Contract Giver is ultimately
responsible to ensure processes are in place to assure the control of outsourced
activities. These processes should incorporate quality risk management principles and
notably include:
7.5 Prior to outsourcing activities, the Contract Giver is responsible for assessing
the legality, suitability and the competence of the Contract Acceptor to carry out
successfully the outsourced activities. The Contract Giver is also responsible for
ensuring by means of the Contract that the principles and guidelines of GMP as
interpreted in this Guide are followed.
7.6 The Contract Giver should provide the Contract Acceptor with all the
information and knowledge necessary to carry out the contracted operations correctly
in accordance with regulations in force, and the Marketing Authorisation for the
product concerned. The Contract Giver should ensure that the Contract Acceptor is
fully aware of any problems associated with the product or the work which might
pose a hazard to his premises, equipment, personnel, other materials or other products.
7.7 The Contract Giver should monitor and review the performance of the
Contract Acceptor and the identification and implementation of any needed
improvement.
7.8 The Contract Giver should be responsible for reviewing and assessing the
records and the results related to the outsourced activities. He should also ensure,
either by himself, or based on the confirmation of the Contract Acceptor’s Qualified
Person, that all products and materials delivered to him by the Contract Acceptor have
been processed in accordance with GMP and the marketing authorisation.
The Contract Acceptor
7.9 The Contract Acceptor must be able to carry out satisfactorily the work
ordered by the Contract Giver such as having adequate premises, equipment,
knowledge, experience, and competent personnel.
7.10 The Contract Acceptor should ensure that all products, materials and
knowledge delivered to him are suitable for their intended purpose.
7.11 The Contract Acceptor should not subcontract to a third party any of the work
entrusted to him under the Contract without the Contract Giver’s prior evaluation and
approval of the arrangements. Arrangements made between the Contract Acceptor
and any third party should ensure that information and knowledge, including those
from assessments of the suitability of the third party, are made available in the same
way as between the original Contract Giver and Contract Acceptor.
7.12 The Contract Acceptor should not make unauthorized changes, outside the
terms of the Contract, which may adversely affect the quality of the outsourced
activities for the Contract Giver.
7.13 The Contract Acceptor should understand that outsourced activities, including
contract analysis, may be subject to inspection by the competent authorities.
The Contract
7.14 A Contract should be drawn up between the Contract Giver and the Contract
Acceptor which specifies their respective responsibilities and communication
processes relating to the outsourced activities. Technical aspects of the Contract
should be drawn up by competent persons suitably knowledgeable in related
outsourced activities and Good Manufacturing Practice. All arrangements for
outsourced activities must be in accordance with regulations in force and the
Marketing Authorisation for the product concerned and agreed by both parties.
7.15 The Contract should describe clearly who undertakes each step of the
outsourced activity, e.g. knowledge management, technology transfer, supply chain,
subcontracting, quality and purchasing of materials, testing and releasing materials,
undertaking production and quality controls (including in-process controls, sampling
and analysis).
7.16 All records related to the outsourced activities, e.g. manufacturing, analytical
and distribution records, and reference samples, should be kept by, or be available to,
the Contract Giver. Any records relevant to assessing the quality of a product in the
event of complaints or a suspected defect or to investigating in the case of a suspected
falsified product must be accessible and specified in the relevant procedures of the
Contract Giver.
7.17 The Contract should permit the Contract Giver to audit outsourced activities,
performed by the Contract Acceptor or his mutually agreed subcontractors

More Related Content

Similar to Chương 7. Tài liệu EU GMP.pdf

Economic operators and post market surveillance under the proposed EU medicin...
Economic operators and post market surveillance under the proposed EU medicin...Economic operators and post market surveillance under the proposed EU medicin...
Economic operators and post market surveillance under the proposed EU medicin...
Erik Vollebregt
 
BRCGS for Food Safety - issue 9 (Draft).pdf
BRCGS for Food Safety - issue 9 (Draft).pdfBRCGS for Food Safety - issue 9 (Draft).pdf
BRCGS for Food Safety - issue 9 (Draft).pdf
hodahassan26
 

Similar to Chương 7. Tài liệu EU GMP.pdf (20)

HDBS 4, phụ lục 9 GMP - WHO, bảo dưỡng kho bảo quản
HDBS 4, phụ lục 9 GMP - WHO, bảo dưỡng kho bảo quảnHDBS 4, phụ lục 9 GMP - WHO, bảo dưỡng kho bảo quản
HDBS 4, phụ lục 9 GMP - WHO, bảo dưỡng kho bảo quản
 
Economic operators and post market surveillance under the proposed EU medicin...
Economic operators and post market surveillance under the proposed EU medicin...Economic operators and post market surveillance under the proposed EU medicin...
Economic operators and post market surveillance under the proposed EU medicin...
 
What Is An Assistant Drug Controller (Adc) Noc In India And Why Is It Importa...
What Is An Assistant Drug Controller (Adc) Noc In India And Why Is It Importa...What Is An Assistant Drug Controller (Adc) Noc In India And Why Is It Importa...
What Is An Assistant Drug Controller (Adc) Noc In India And Why Is It Importa...
 
Final_Schedule M2.pdf
Final_Schedule M2.pdfFinal_Schedule M2.pdf
Final_Schedule M2.pdf
 
Hdbs 4, phụ lục 9 gmp who, bảo dưỡng kho bảo quản
Hdbs 4, phụ lục 9 gmp who, bảo dưỡng kho bảo quảnHdbs 4, phụ lục 9 gmp who, bảo dưỡng kho bảo quản
Hdbs 4, phụ lục 9 gmp who, bảo dưỡng kho bảo quản
 
Supplement 4- Annex9- WHO guideline: Maintenance of storage facilities
Supplement 4- Annex9- WHO guideline: Maintenance of storage facilitiesSupplement 4- Annex9- WHO guideline: Maintenance of storage facilities
Supplement 4- Annex9- WHO guideline: Maintenance of storage facilities
 
Q1 Medical Devices Regulation - practical consequences for manufacturers
Q1 Medical Devices Regulation - practical consequences for manufacturersQ1 Medical Devices Regulation - practical consequences for manufacturers
Q1 Medical Devices Regulation - practical consequences for manufacturers
 
EU Pesticides Consultation
EU Pesticides ConsultationEU Pesticides Consultation
EU Pesticides Consultation
 
Q5 e step4
Q5 e step4Q5 e step4
Q5 e step4
 
Circular 18/2019/TT-BYT: GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP) FOR...
Circular 18/2019/TT-BYT: GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP) FOR...Circular 18/2019/TT-BYT: GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP) FOR...
Circular 18/2019/TT-BYT: GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP) FOR...
 
Contract production, analysis and other activities - WHO GMP training
Contract production, analysis and other activities - WHO GMP trainingContract production, analysis and other activities - WHO GMP training
Contract production, analysis and other activities - WHO GMP training
 
Hệ thống quản lý chất lượng JGMP - GMP Nhật Bản
Hệ thống quản lý chất lượng JGMP - GMP Nhật BảnHệ thống quản lý chất lượng JGMP - GMP Nhật Bản
Hệ thống quản lý chất lượng JGMP - GMP Nhật Bản
 
Adoption of the pics guide to gmp pe009 13
Adoption of the pics guide to gmp pe009 13Adoption of the pics guide to gmp pe009 13
Adoption of the pics guide to gmp pe009 13
 
ANDA, IMPD & IB
ANDA, IMPD & IBANDA, IMPD & IB
ANDA, IMPD & IB
 
cGMP.pptx
cGMP.pptxcGMP.pptx
cGMP.pptx
 
New legal obligations and liability under MDR and IVDR
New legal obligations and liability under MDR and IVDRNew legal obligations and liability under MDR and IVDR
New legal obligations and liability under MDR and IVDR
 
GOOD MANUFACTURING PRACTICE
GOOD MANUFACTURING PRACTICEGOOD MANUFACTURING PRACTICE
GOOD MANUFACTURING PRACTICE
 
BRCGS for Food Safety - issue 9 (Draft).pdf
BRCGS for Food Safety - issue 9 (Draft).pdfBRCGS for Food Safety - issue 9 (Draft).pdf
BRCGS for Food Safety - issue 9 (Draft).pdf
 
Tiêu chuẩn GMP EU chương 4. Tiêu chí về hệ thống Tài liệu
Tiêu chuẩn GMP EU chương 4. Tiêu chí về hệ thống Tài liệuTiêu chuẩn GMP EU chương 4. Tiêu chí về hệ thống Tài liệu
Tiêu chuẩn GMP EU chương 4. Tiêu chí về hệ thống Tài liệu
 
License
LicenseLicense
License
 

More from Công ty cổ phần GMPc Việt Nam | Tư vấn GMP, HS GMP, CGMP ASEAN, EU GMP, WHO GMP

More from Công ty cổ phần GMPc Việt Nam | Tư vấn GMP, HS GMP, CGMP ASEAN, EU GMP, WHO GMP (20)

Quy trình đánh giá duy trì đáp ứng “ thực hành tốt phòng thí nghiệm” (GLP)
Quy trình đánh giá duy trì đáp ứng “ thực hành tốt phòng thí nghiệm” (GLP)Quy trình đánh giá duy trì đáp ứng “ thực hành tốt phòng thí nghiệm” (GLP)
Quy trình đánh giá duy trì đáp ứng “ thực hành tốt phòng thí nghiệm” (GLP)
 
Quy trình Đánh giá đáp ứng GLP để cấp ĐĐKKDD.pdf
Quy trình Đánh giá đáp ứng GLP để cấp ĐĐKKDD.pdfQuy trình Đánh giá đáp ứng GLP để cấp ĐĐKKDD.pdf
Quy trình Đánh giá đáp ứng GLP để cấp ĐĐKKDD.pdf
 
Quy trình Đánh giá đáp ứng GMP để cấp GCN ĐĐK.pdf
Quy trình Đánh giá đáp ứng GMP để cấp GCN ĐĐK.pdfQuy trình Đánh giá đáp ứng GMP để cấp GCN ĐĐK.pdf
Quy trình Đánh giá đáp ứng GMP để cấp GCN ĐĐK.pdf
 
Quy trình kiểm soát thay đổi sau khi cấp Giấy chứng nhận GMP/Giấy chứng nhận ...
Quy trình kiểm soát thay đổi sau khi cấp Giấy chứng nhận GMP/Giấy chứng nhận ...Quy trình kiểm soát thay đổi sau khi cấp Giấy chứng nhận GMP/Giấy chứng nhận ...
Quy trình kiểm soát thay đổi sau khi cấp Giấy chứng nhận GMP/Giấy chứng nhận ...
 
Quy trình chuẩn bị, kiểm tra và cấp Giấy chứng nhận “Thực hành tốt sản xuất m...
Quy trình chuẩn bị, kiểm tra và cấp Giấy chứng nhận “Thực hành tốt sản xuất m...Quy trình chuẩn bị, kiểm tra và cấp Giấy chứng nhận “Thực hành tốt sản xuất m...
Quy trình chuẩn bị, kiểm tra và cấp Giấy chứng nhận “Thực hành tốt sản xuất m...
 
Quy trình đánh giá đáp ứng “Thực hành tốt sản xuất thuốc, nguyên liệu làm thu...
Quy trình đánh giá đáp ứng “Thực hành tốt sản xuất thuốc, nguyên liệu làm thu...Quy trình đánh giá đáp ứng “Thực hành tốt sản xuất thuốc, nguyên liệu làm thu...
Quy trình đánh giá đáp ứng “Thực hành tốt sản xuất thuốc, nguyên liệu làm thu...
 
Quy trình xử lý đối với các vi phạm nghiêm trọng phát hiện trong quá trình đá...
Quy trình xử lý đối với các vi phạm nghiêm trọng phát hiện trong quá trình đá...Quy trình xử lý đối với các vi phạm nghiêm trọng phát hiện trong quá trình đá...
Quy trình xử lý đối với các vi phạm nghiêm trọng phát hiện trong quá trình đá...
 
Quy trình xử lý khiếu nại về kiểm tra GMP
Quy trình xử lý khiếu nại về kiểm tra GMPQuy trình xử lý khiếu nại về kiểm tra GMP
Quy trình xử lý khiếu nại về kiểm tra GMP
 
Quy trình xử lý và chia sẻ thông tin liên quan đến chất lượng vắc xin và tình...
Quy trình xử lý và chia sẻ thông tin liên quan đến chất lượng vắc xin và tình...Quy trình xử lý và chia sẻ thông tin liên quan đến chất lượng vắc xin và tình...
Quy trình xử lý và chia sẻ thông tin liên quan đến chất lượng vắc xin và tình...
 
Quy trình đánh giá duy trì đáp ứng “Thực hành tốt sản xuất thuốc, nguyên liệu...
Quy trình đánh giá duy trì đáp ứng “Thực hành tốt sản xuất thuốc, nguyên liệu...Quy trình đánh giá duy trì đáp ứng “Thực hành tốt sản xuất thuốc, nguyên liệu...
Quy trình đánh giá duy trì đáp ứng “Thực hành tốt sản xuất thuốc, nguyên liệu...
 
Nguyên tắc, tiêu chuẩn thực hành tốt sản xuất thuốc của Liên minh Châu Âu
Nguyên tắc, tiêu chuẩn thực hành tốt sản xuất thuốc của Liên minh Châu ÂuNguyên tắc, tiêu chuẩn thực hành tốt sản xuất thuốc của Liên minh Châu Âu
Nguyên tắc, tiêu chuẩn thực hành tốt sản xuất thuốc của Liên minh Châu Âu
 
Tài liệu lập báo cáo đầu tư _ Luật Đầu Tư 612020QH14
Tài liệu lập báo cáo đầu tư _ Luật Đầu Tư 612020QH14Tài liệu lập báo cáo đầu tư _ Luật Đầu Tư 612020QH14
Tài liệu lập báo cáo đầu tư _ Luật Đầu Tư 612020QH14
 
NGHỊ ĐỊNH 152021NĐ-CP - QUY ĐỊNH CHI TIẾT MỘT SỐ NỘI DUNG VỀ QUẢN LÝ DỰ ÁN ĐẦ...
NGHỊ ĐỊNH 152021NĐ-CP - QUY ĐỊNH CHI TIẾT MỘT SỐ NỘI DUNG VỀ QUẢN LÝ DỰ ÁN ĐẦ...NGHỊ ĐỊNH 152021NĐ-CP - QUY ĐỊNH CHI TIẾT MỘT SỐ NỘI DUNG VỀ QUẢN LÝ DỰ ÁN ĐẦ...
NGHỊ ĐỊNH 152021NĐ-CP - QUY ĐỊNH CHI TIẾT MỘT SỐ NỘI DUNG VỀ QUẢN LÝ DỰ ÁN ĐẦ...
 
Tài liệu lập báo cáo đầu tư _LUẬT XÂY DỰNG SỬA ĐỔI 2020
Tài liệu lập báo cáo đầu tư _LUẬT XÂY DỰNG SỬA ĐỔI 2020Tài liệu lập báo cáo đầu tư _LUẬT XÂY DỰNG SỬA ĐỔI 2020
Tài liệu lập báo cáo đầu tư _LUẬT XÂY DỰNG SỬA ĐỔI 2020
 
Tài liệu lập Dự án đầu tư - LUẬT XÂY DỰNG 2014
Tài liệu lập Dự án đầu tư - LUẬT XÂY DỰNG 2014Tài liệu lập Dự án đầu tư - LUẬT XÂY DỰNG 2014
Tài liệu lập Dự án đầu tư - LUẬT XÂY DỰNG 2014
 
Danh sách các dược liệu đã được đánh giá đạt cấp Giấy chứng nhận GACP
Danh sách các dược liệu đã được đánh giá đạt cấp Giấy chứng nhận GACPDanh sách các dược liệu đã được đánh giá đạt cấp Giấy chứng nhận GACP
Danh sách các dược liệu đã được đánh giá đạt cấp Giấy chứng nhận GACP
 
2024 List of gmp project (Updated T1) .pdf
2024 List of gmp project  (Updated T1) .pdf2024 List of gmp project  (Updated T1) .pdf
2024 List of gmp project (Updated T1) .pdf
 
Danh mục dự án đã được tư vấn bởi GMPC 2011-2023 Cập nhật T1.2024.pdf
Danh mục dự án đã được tư vấn bởi GMPC 2011-2023 Cập nhật T1.2024.pdfDanh mục dự án đã được tư vấn bởi GMPC 2011-2023 Cập nhật T1.2024.pdf
Danh mục dự án đã được tư vấn bởi GMPC 2011-2023 Cập nhật T1.2024.pdf
 
PROFILE GMPC VIETNAM TIENG ANH - 2024.pdf
PROFILE GMPC VIETNAM TIENG ANH - 2024.pdfPROFILE GMPC VIETNAM TIENG ANH - 2024.pdf
PROFILE GMPC VIETNAM TIENG ANH - 2024.pdf
 
Profile GMPC Viet Nam - Tieng Viet - 2024.pdf
Profile GMPC Viet Nam - Tieng Viet - 2024.pdfProfile GMPC Viet Nam - Tieng Viet - 2024.pdf
Profile GMPC Viet Nam - Tieng Viet - 2024.pdf
 

Recently uploaded

Mastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial FreedomMastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial Freedom
FatimaMary4
 

Recently uploaded (20)

TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Ed...
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Ed...TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Ed...
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Ed...
 
Mastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial FreedomMastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial Freedom
 
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal Testimony
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 

Chương 7. Tài liệu EU GMP.pdf

  • 1. EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health Systems and Products Medicinal Products - Quality, safety and efficacy Brussels, SANCO/AM/sl/ddg1.d.6(2012)860362 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use Chapter 7 Outsourced Activities Legal basis for publishing the detailed guidelines: Article 47 of Directive 2001/83/EC on the Community code relating to medicinal products for human use and Article 51 of Directive 2001/82/EC on the Community code relating to veterinary medicinal products. This document provides guidance for the interpretation of the principles and guidelines of good manufacturing practice (GMP) for medicinal products as laid down in Directive 2003/94/EC for medicinal products for human use and Directive 91/412/EEC for veterinary use. Status of the document: revision 1 Reasons for changes: In view of the ICH Q10 guideline on the Pharmaceutical Quality System, Chapter 7 of the GMP Guide has been revised in order to provide updated guidance on outsourced GMP regulated activities beyond the current scope of contract manufacture and analysis operations. The title of the Chapter has been changed to reflect this. Deadline for coming into operation: 31 January 2013 Ref. Ares(2012)778531 - 28/06/2012
  • 2. Commission Européenne, B-1049 Bruxelles / Europese Commissie, B-1049 Brussel – Belgium. Telephone: (32-2) 299 11 11 Principle Any activity covered by the GMP Guide that is outsourced should be appropriately defined, agreed and controlled in order to avoid misunderstandings which could result in a product or operation of unsatisfactory quality. There must be a written Contract between the Contract Giver and the Contract Acceptor which clearly establishes the duties of each party. The Quality Management System of the Contract Giver must clearly state the way that the Qualified Person certifying each batch of product for release exercises his full responsibility. Note: This Chapter deals with the responsibilities of manufacturers towards the Competent Authorities of the Member States with respect to the granting of marketing and manufacturing authorizations. It is not intended in any way to affect the respective liability of Contract Acceptors and Contract Givers to consumers; this is governed by other provisions of Community and national law. General 7.1 There should be a written Contract covering the outsourced activities, the products or operations to which they are related, and any technical arrangements made in connection with it. 7.2 All arrangements for the outsourced activities including any proposed changes in technical or other arrangements should be in accordance with regulations in force, and the Marketing Authorisation for the product concerned, where applicable. 7.3 Where the marketing authorization holder and the manufacturer are not the same, appropriate arrangements should be in place, taking into account the principles described in this chapter. The Contract Giver 7.4 The pharmaceutical quality system of the Contract Giver should include the control and review of any outsourced activities. The Contract Giver is ultimately responsible to ensure processes are in place to assure the control of outsourced activities. These processes should incorporate quality risk management principles and notably include: 7.5 Prior to outsourcing activities, the Contract Giver is responsible for assessing the legality, suitability and the competence of the Contract Acceptor to carry out successfully the outsourced activities. The Contract Giver is also responsible for ensuring by means of the Contract that the principles and guidelines of GMP as interpreted in this Guide are followed. 7.6 The Contract Giver should provide the Contract Acceptor with all the information and knowledge necessary to carry out the contracted operations correctly in accordance with regulations in force, and the Marketing Authorisation for the product concerned. The Contract Giver should ensure that the Contract Acceptor is
  • 3. fully aware of any problems associated with the product or the work which might pose a hazard to his premises, equipment, personnel, other materials or other products. 7.7 The Contract Giver should monitor and review the performance of the Contract Acceptor and the identification and implementation of any needed improvement. 7.8 The Contract Giver should be responsible for reviewing and assessing the records and the results related to the outsourced activities. He should also ensure, either by himself, or based on the confirmation of the Contract Acceptor’s Qualified Person, that all products and materials delivered to him by the Contract Acceptor have been processed in accordance with GMP and the marketing authorisation. The Contract Acceptor 7.9 The Contract Acceptor must be able to carry out satisfactorily the work ordered by the Contract Giver such as having adequate premises, equipment, knowledge, experience, and competent personnel. 7.10 The Contract Acceptor should ensure that all products, materials and knowledge delivered to him are suitable for their intended purpose. 7.11 The Contract Acceptor should not subcontract to a third party any of the work entrusted to him under the Contract without the Contract Giver’s prior evaluation and approval of the arrangements. Arrangements made between the Contract Acceptor and any third party should ensure that information and knowledge, including those from assessments of the suitability of the third party, are made available in the same way as between the original Contract Giver and Contract Acceptor. 7.12 The Contract Acceptor should not make unauthorized changes, outside the terms of the Contract, which may adversely affect the quality of the outsourced activities for the Contract Giver. 7.13 The Contract Acceptor should understand that outsourced activities, including contract analysis, may be subject to inspection by the competent authorities. The Contract 7.14 A Contract should be drawn up between the Contract Giver and the Contract Acceptor which specifies their respective responsibilities and communication processes relating to the outsourced activities. Technical aspects of the Contract should be drawn up by competent persons suitably knowledgeable in related outsourced activities and Good Manufacturing Practice. All arrangements for outsourced activities must be in accordance with regulations in force and the Marketing Authorisation for the product concerned and agreed by both parties. 7.15 The Contract should describe clearly who undertakes each step of the outsourced activity, e.g. knowledge management, technology transfer, supply chain, subcontracting, quality and purchasing of materials, testing and releasing materials,
  • 4. undertaking production and quality controls (including in-process controls, sampling and analysis). 7.16 All records related to the outsourced activities, e.g. manufacturing, analytical and distribution records, and reference samples, should be kept by, or be available to, the Contract Giver. Any records relevant to assessing the quality of a product in the event of complaints or a suspected defect or to investigating in the case of a suspected falsified product must be accessible and specified in the relevant procedures of the Contract Giver. 7.17 The Contract should permit the Contract Giver to audit outsourced activities, performed by the Contract Acceptor or his mutually agreed subcontractors